A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies

Lydia Usha, Michael W. Sill, Kathleen M. Darcy, Doris M. Benbrook, Jean Hurteau, David P. Michelin, Robert S. Mannel, Parviz Hanjani, Koen De Geest, Andrew K. Godwin

Gynecologic Oncology · 2011 · 50 citations · 47 references

Concepts

References

47